Sarepta Therapeutics Inc
XMUN:AB3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sarepta Therapeutics Inc
XMUN:AB3A
|
US |
Wall St Price Targets
AB3A Price Targets Summary
Sarepta Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for AB3A is 19.92 EUR with a low forecast of 4.41 EUR and a high forecast of 34.82 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AB3A's stock price target?
Price Target
19.92
EUR
According to Wall Street analysts, the average 1-year price target for AB3A is 19.92 EUR with a low forecast of 4.41 EUR and a high forecast of 34.82 EUR.
What is the Revenue forecast for Sarepta Therapeutics Inc?
Projected CAGR
-12%
Over the last 13 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 3 years is -12%.
What is the Gross Profit forecast for Sarepta Therapeutics Inc?
Projected CAGR
-8%
The compound annual growth rate for Gross Profit over the next 3 years is -8%.
